secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oscar Health, Inc. (OSCR)
CIK:        0001568651
Form:       8-K
Filed at:   2024-08-07T23:59:59+00:00
Accession:  0001568651-24-000021
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oscar Health Q2 net income $56.2M, rev $2.2B +46% YoY, raises FY guidance
-------------------------------------------------------------------------

- Net income of $56.2M ($0.20 diluted EPS) vs. loss of $15.5M a year ago.
- Total revenue $2.2B, up 46% YoY driven by higher membership and rate increases.
- Adjusted EBITDA $104.1M, up from $35.6M in Q2 2023; MLR improved 90bps to 79.0%.
- Raised FY 2024 revenue guidance to $9.0-9.1B (prior $8.3-8.4B) and Adj EBITDA to $160-210M (prior $125-175M).
- Total membership 1.58M, up 63% YoY, driven by Individual & Small Group growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1568651/000156865124000021/0001568651-24-000021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1568651/000156865124000021/oscr-20240807.htm
  HTML page:      https://secwatch.observer/filing/0001568651-24-000021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer